Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Giuseppe Curigliano
Based on 105 articles published since 2008
||||
Expertise Level
The expertise of Giuseppe Curigliano ranks in the
  • Top 0.0098%
  • ... of 255,217 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 105 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Curigliano, G   ·   Curigliano, Giuseppe
Work Locations
Details
Most likely:    European Institute of Oncology      
2018
  • University of Milano, Department of Oncology and Hemato-Oncology, Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 30032791
  • a Division of Early Drug Development , European Institute of Oncology , Milan , Italy. · b Department of Oncology and Hematology , University of Milan , Milan , Italy. · Pubmed 29355400
  • Women and Children's Division, Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway; Department of Bowel Cancer Screening, Cancer Registry of Norway, Oslo, Norway. · Hexal AG, Holzkirchen, Germany. · European Institute of Oncology, Division of New Drug Development, Italy; Department of Oncology and Hematology, University of Milano, Milano, Italy. Electronic address: · Pubmed 29227817
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • European Institute of Oncology, Milano, Italy. Electronic address: · Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milano, Italy. · European Institute of Oncology, Milano, Italy; University of Milan, Milano, Italy. · European Institute of Oncology, Milano, Italy. · Pubmed 27876474
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • a Division of Early Drug Development , European Institute of Oncology , Milan , Italy. · b Department of Oncology and Hematology , University of Milan , Milan , Italy. · Pubmed 28718331
  • Giuseppe Curigliano and Carmen Criscitiello, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 28661760
  • a Early Drugs Development for Innovative Therapies Division , European Institute of Oncology , Milan , Italy. · b Division of Senology , European Institute of Oncology , Milan , Italy. · c School of Medicine , University of Milano , Milan , Italy. · Pubmed 28395543
  • Azienda Ospedaliero Universitaria Careggi - University of Florence, Largo G.A. Brambilla 3, 50134, Florence, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Azienda Ospedaliero Universitaria Careggi - University of Florence, Largo G.A. Brambilla 3, 50134, Florence, Italy. · Breast Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy. · Medical Oncology Unit, Presidio Ospedaliero Felice Lotti, Pontedera, Italy. · UOC di Oncologia, Ospedale Versilia, Istituto Toscano Tumori, Lido di Camaiore, Italy. · Dipartimento Oncologico ASST - Bergamo Ovest, Treviglio, Italy. · Medical Oncology Unit, Ospedale Misericordia, Grosseto, Italy. · Division of Medical Oncology 2, Istituto Oncologico Veneto, Padua, Italy. · Medical Oncology Unit, Azienda Ospedaliera Sant'Andrea, Rome, Italy. · Breast Unit, Santa Maria Annunziata Hospital, Florence, Italy. · SC Oncologia, Ospedale Ss. Antonio e Biagio e C. Arrigo, Alessandria, Italy. · Medicina Interna 1, Ospedale San Giuseppe, Empoli, Italy. · Pubmed 28364270
  • Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St., Dublin, 7, Ireland. · Division of Early Drug Development, Istituto Europeo di Oncologia, Milan, Italy. · Clinical Investigational Unit, Institut Curie, Paris, France. · Breast UnitKliniken Essen-Mitte, Essen, Germany. · Department of Obstetrics & Gynecology, St.-Johannes-Hospital, Dortmund, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-EMN, Erlangen, Germany. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Department of Medical Oncology, Centre Leon Berard, Lyon, France. · Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Department of Clinical Oncology, Nottingham University Hospital NHS Trust (City campus), Nottingham, UK. · Unit of Medical Oncology, Santa Chiara Hospital, Trento, Italy. · Division of Hematology/Oncology, University of Tennessee Health Science Center, The West Clinic, Medical Oncology, Memphis, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · MGH Cancer Center, Massachusetts General Hospital, Boston, USA. · Pubmed 28176175
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Medical Oncology, Karmanos Cancer Institute, Detroit, MI, USA. · Yale Cancer Center, New Haven, CT, USA. · Breast Cancer Research Program, Stanford Cancer Institute, Stanford, CA, USA. · Pfizer Oncology, Groton, CT, USA. · Pfizer Oncology, Milan, Italy. · Pfizer Oncology, San Diego, CA, USA. · Pubmed 27906684
  • Division of Early Drug Development, European Institute of Oncology, Milano, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, Italy; Department of Haematology and Oncology, University of Milano, Italy. · Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy. · Division of Early Drug Development, European Institute of Oncology, Milano, Italy; Department of Haematology and Oncology, University of Milano, Italy. Electronic address: · Pubmed 29154173
  • Department of Radiological Science and Radiation Therapy, IEO European Institute of Oncology, Milan, Italy; Department of Oncology, Università degli Studi di Milano, Milan, Italy. Electronic address: · Università degli Studi di Milano, Postgraduation School in Radiodiagnostics, Milan, Italy. Electronic address: · Università degli Studi di Milano, Postgraduation School in Radiodiagnostics, Milan, Italy. Electronic address: · Università degli Studi di Milano, Postgraduation School in Radiodiagnostics, Milan, Italy; Present address: Department of Imaging, CDI Centro Diagnostico Italiano, Via Simone Saint Bon, Milan, Italy. Electronic address: · New Drugs and Early Drug Development for Innovative Therapies Division, IEO European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, IEO European Institute of Oncology, Milan, Italy. Electronic address: · Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia and Division of Radiology, National Center of Oncological Hadrontherapy (CNAO Foundation), Italy. Electronic address: · Pubmed 28987705
  • Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Medical Oncology, Institut Jules Bordet, UniversitÕ Libre de Bruxelles, Brussels, Belgium. · Tumor and Breast Center ZeTuP, St. Gallen. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N. Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku, Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 28838210
  • APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: · European Institute of Oncology, Milan, Italy. · University Medical Center, Hamburg, Germany. · Copenhagen University Hospital, Copenhagen, Denmark. · Sussex Health Outcomes, Research & Education in Cancer (SHORE-C), University of Sussex, East Sussex, UK. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University Hospital Jean Minjoz, Besançon, France. · Pubmed 28549309
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Istituto Europeo di Oncologia, Division of Early Drug Development for Innovative Therapies, Via Ripamonti 435, 20133 Milano, Italy. Electronic address: · Istituto Europeo di Oncologia, Division of Early Drug Development for Innovative Therapies, Via Ripamonti 435, 20133 Milano, Italy. · Division of Pathology, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy; University of Milan, Breast Cancer Program, Via Ripamonti 435, 20133 Milano, Italy. · Pubmed 27866835
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Pubmed 27810700
2016
  • Division of Experimental Cancer Medicine, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 27600532
  • Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · Department of Breast Oncology Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA. Electronic address: · Department of Surgery, McGill Hospital, Boston, MA, USA. Electronic address: · Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · Department of Clinical Medicine and Surgery, University Federico II, Corso Umberto I 40, Naples, Italy. Electronic address: · Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · General Surgery, Department of Advanced Biomedical Science, University Federico II, Corso Umberto I 40, Naples, Italy. Electronic address: · Department of Surgery, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 27825710
  • Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 27744144
  • IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA. · Harvard T. H. Chan School of Public Health, Boston, MA, USA. · IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary. · Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 27372069
  • Istituto Europeo di Oncologia, via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Servicio Oncologia Médica, Vall d'Hebron University Hospital, Vall d'Hebron 119-129, 08035, Barcelona, Spain. · The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX, 77030, USA. · Istituto Oncologico Veneto, Via Gattamelata 64, 35128, Padua, Italy; University of Padova, Via Giustiniani 22, 35121, Padua, Italy. · University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands; Erasmus Medical Center Cancer Institute, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Highlands Oncology Group, 3232 N North Hills Blvd, Fayetteville, AR, 72703, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. · Oncología Médica, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. · Centre Jean Perrin, Unicancer and EA 4677 Université d'Auvergne, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Novartis Institutes for BioMedical Research, 230 Massachusetts Avenue, Cambridge, MA, 02139, USA. · University of California, Los Angeles, 2825 Santa Monica Blvd, Suite 211, Santa Monica, CA, 90404, USA. · Pubmed 27336726
  • Levine Cancer Institute, Charlotte, NC, USA. · Mission Health Asheville, Asheville, NC, USA. · Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141, Milan, Italy. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Sylvester Comprehensive Cancer Center at Deerfield Beach, Miller School of Medicine, University of Miami, Miami, FL, USA. · The Northern Hospital, Cooper St, Epping, Australia. · Department of Medical Oncology, Léon-Bérard Centre, Lyon, France. · Oncology-Hematology Department, Grand Hopital de Charleroi, Charleroi, Belgium. · Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, WA, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Clinique du sein, Centre du Cancer, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Oncology, KU Leuven and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Roswell Park Cancer Institute, Buffalo, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · Vianova-Biosciences, Lasne, Belgium. · Pubmed 26993131
  • Department of Experimental Oncology, European Institute of Oncology, Milan 20141, Italy. · Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan 20139, Italy. · Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan 20141, Italy. · School of Medicine, University of Milan, Milan 20122, Italy. · Biobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Milan 20141, Italy. · Department of Oncology, University of Milan, Milan 20139, Italy. · Pubmed 27779108
  • Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milano, Italy. · Division of Epidemiology and Biostatistics, Istituto Europeo di Oncologia, Milano, Italy. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 27323400
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy Program of Breast Health (Senology), European Institute of Oncology, Milan, Italy · Program of Breast Health (Senology), European Institute of Oncology, Milan, Italy. · Pubmed 26002609
  • Division of Experimental Cancer Medicine, European Institute of Oncology, Milan, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy; Breast Center, Baylor College of Medicine, Houston, TX, USA. · Medical Oncology, Istituto Nazionale Tumori - IRCCS Fondazione Pascale, Napoli, Italy. · Medical Oncology, Azienda Ospedaliera Universitaria Federico II, Napoli, Italy. · General Surgery, Department of Advanced Biomedical Science, University Federico II, Napoli, Italy. · Department of Surgery, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. · General Surgery, Department of Advanced Biomedical Science, University Federico II, Napoli, Italy. Electronic address: · Pubmed 26238477
  • Department of Pathology, Yale University, New Haven, USA · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, USA. · Oncology Centre, Cambridge University Hospitals National Health Services Foundation Trust, Cambridge, UK. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Essligen, Germany. · Institute of Pathology, Medical University of Graz, Graz Breast Center Salzburg, Paracelsus Medical University, University Hospital Salzburg, Salzburg, Austria. · German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA. · Institute of Pathology, Charité Hospital, Campus Mitte, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux. · Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh, UK. · Pubmed 26019189
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Affiliations of authors: Division of Experimental Cancer Medicine, European Institute of Oncology, Milan, Italy (AE, CC, GC). · Affiliations of authors: Division of Experimental Cancer Medicine, European Institute of Oncology, Milan, Italy (AE, CC, GC). · Pubmed 26063887
  • European Institute of Oncology, Medical Oncology, Milan, Italy. Electronic address: · European Institute of Oncology, Division of Epidemiology and Biostatistics, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · European Institute of Oncology, Medical Oncology, Milan, Italy. · European Institute of Oncology, Division of Pathology and Laboratory Medicine, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · European Institute of Oncology, Division of Plastic Reconstruction Surgery, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, Milan, Italy. · Pubmed 25908443
2014
  • Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 25279960
  • Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milano, Italy · Division of Hematology/Medical Oncology and Cancer Biology, Mayo Clinic Cancer Center, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 24950980
  • Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 24727984
  • Department of Medical Oncology, University Hospital Jean Minjoz, Besançon · Medical Oncology Department, APHP Hôpital Tenon, Paris UPMC, Institut Universitaire de Cancérologie, Paris, France. · Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, UK. · Global Medical Affairs, F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Pubmed 25070545
  • European Institute of Oncology, Medical Oncology, Milan, Italy · European Institute of Oncology, Division of Epidemiology and Biostatistics and Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · European Institute of Oncology, Medical Oncology, Milan, Italy. · European Institute of Oncology, Division of Plastic Reconstruction Surgery, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, Milan, Italy. · Pubmed 25368274
  • Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Breast Oncology, National Cancer Institute "Fondazione Pascale", Naples, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Napoli, Italy. · Department of Advanced Medical Sciences, Operative Unit of General Surgery and Transplants, University of Naples Federico II, Napoli, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24314620
  • European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. Electronic address: · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy. · European Institute of Oncology, Division of Pathology, via Ripamonti 435, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, via Bicocca degli Arcimboldi 8, 20126 Milan, Italy. · European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. · Second University of Naples, Medical Oncology, via Pansini 5, Naples, Italy. · Pubmed 24269135
2013
  • Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 24074802
  • Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milano, Italy. Electronic address: · Pubmed 23958375
2012
  • Division of Medical Oncology, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italia. · Pubmed 22229343
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 21764517
2011
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 22015297
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano 20141, Italy. · Pubmed 22043054
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 21343379
  • Department of Medicine, Division of Medical Oncology, Milano, Italy. · Pubmed 20610479
2009
  • European Institute of Oncology, Department of Medicine, Division of Medical Oncology, Via Ripamonti 435, Milan, Italy. · Pubmed 19914543
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 19884553
2017
  • New Drugs Development Division, European Institute of Oncology, Milan, Italy. · Pubmed 28914645
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Pubmed 28872469
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2015
  • aDivision of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan bDipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, Napoli, Italy. · Pubmed 26397764
  • Medical Oncology Unit (VA, ABe), University of Brescia, and Breast Unit (RP, LV, ELS) Spedali Civili Hospital, Brescia, Italy; U.O. Multidisciplinare di Patologia Mammaria, S.S. Terapia Molecolare e Farmacogenomica, AZ. Istituti Ospitalieri di Cremona, Cremona, Italy (DG, AR, MRC, LD, ABo); Departments of Radiation Oncology (TB) and Pathology (FS), University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA (MC); Division of Experimental Therapeutics, Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy (GC); Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine (MGD), and Medical Oncology Unit (SDC), Fondazione IRCCS - Istituto Nazionale Tumori, Milan, Italy (MGD); Academic Department of Biochemistry, Biochemical Endocrinology (MD), Department of Surgery, Breast Unit (PB), and The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research and Breast Unit (MD, GS), Royal Marsden Hospital, London, UK; Department of Pathology, Melbourne University, Parkville, Australia (SF); Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (ALH); Mount Vernon Cancer Centre, London, UK (AM); Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT (CH); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Division of Medical Oncology, Department of Hemato-oncology, IRCCS Policlinico 'San Matteo' Foundation, Pavia, Italy (PP); Dipartimento Medicina di Laboratorio, SC Anatomia ed Istocitopatologia Diagnostica e di Screening, A.O.U. Città della Salute e della Scienza di Torino, Università di Torino, Turin, Italy (AS); N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia (VS); German Breast Group & University of Frankfurt, Neu-Isenburg, Germany (GvM); The Russell H. Morgan Department of Radiology · Pubmed 26063896
2014
  • Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 25279962
  • Istituto Europeo di Oncologia, Division of Early Drug Development for Innovative Therapies , Via Ripamonti 435, 20133 Milano , Italy +39 02 57489439 ; +39 02 94379224 ; · Pubmed 25107301
  • Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Pubmed 25080998
  • Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 24762078
  • Istituto Europeo di Oncologia, Division of Early Drug Development for Innovative Therapies , Via Ripamonti 435, 20133 Milano , Italy +39 02 57489788 ; +39 02 57489581 ; · Pubmed 24597540
  • Authors' Affiliations: Breast Cancer Program, Division of Early Drug Development, Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan; and Department of Advanced Biomedical Sciences, Operative Unit of General Surgery and Transplants, University Naples Federico II, Napoli, Italy. · Pubmed 24165579
2013
  • Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 24076578
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy. · Pubmed 23915740
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22541668
  • Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy; Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy. Electronic address: · Pubmed 23953055
  • Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. Electronic address: · Pubmed 23777741
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23642529
  • Department of Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 23393126
  • Medical Oncology, European Institute of Oncology , Milan , Italy. · Pubmed 23327413
  • Division of Plastic Reconstruction Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy. · Pubmed 23313014
2012
  • Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Pubmed 21715566
  • European Institute of Oncology, Medical Oncology, Milan, Italy. · Pubmed 22827581
  • Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 23040002
  • Division of Plastic Reconstruction Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22820937
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 22547541
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 22467243
  • Division of Plastic Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22231025
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 22212746
  • Division of Plastic Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 21610155
2011
  • Division of Plastic Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 22024947
  • Division of Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 21295982
  • Divisione di Radiologia, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milano, Italy. · Pubmed 21225368
  • Division of Senology, European Institute of Oncology, IEO, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 20740312
2010
  • Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Pubmed 20920984
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 19967556
  • Division of Medical Oncology, European Institute of Oncology, via Ripamonti 435, Milan, Italy. · Pubmed 19884008
Probable:    University of Milan Statale      
2018
  • University of Milano, Department of Oncology and Hemato-Oncology, Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 30032791
  • a Division of Early Drug Development , European Institute of Oncology , Milan , Italy. · b Department of Oncology and Hematology , University of Milan , Milan , Italy. · Pubmed 29355400
  • Women and Children's Division, Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway; Department of Bowel Cancer Screening, Cancer Registry of Norway, Oslo, Norway. · Hexal AG, Holzkirchen, Germany. · European Institute of Oncology, Division of New Drug Development, Italy; Department of Oncology and Hematology, University of Milano, Milano, Italy. Electronic address: · Pubmed 29227817
2017
  • Division of Early Drug Development, European Institute of Oncology, Milano, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, Italy; Department of Haematology and Oncology, University of Milano, Italy. · Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy. · Division of Early Drug Development, European Institute of Oncology, Milano, Italy; Department of Haematology and Oncology, University of Milano, Italy. Electronic address: · Pubmed 29154173
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2015
  • Medical Oncology Unit (VA, ABe), University of Brescia, and Breast Unit (RP, LV, ELS) Spedali Civili Hospital, Brescia, Italy; U.O. Multidisciplinare di Patologia Mammaria, S.S. Terapia Molecolare e Farmacogenomica, AZ. Istituti Ospitalieri di Cremona, Cremona, Italy (DG, AR, MRC, LD, ABo); Departments of Radiation Oncology (TB) and Pathology (FS), University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA (MC); Division of Experimental Therapeutics, Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy (GC); Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine (MGD), and Medical Oncology Unit (SDC), Fondazione IRCCS - Istituto Nazionale Tumori, Milan, Italy (MGD); Academic Department of Biochemistry, Biochemical Endocrinology (MD), Department of Surgery, Breast Unit (PB), and The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research and Breast Unit (MD, GS), Royal Marsden Hospital, London, UK; Department of Pathology, Melbourne University, Parkville, Australia (SF); Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (ALH); Mount Vernon Cancer Centre, London, UK (AM); Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT (CH); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Division of Medical Oncology, Department of Hemato-oncology, IRCCS Policlinico 'San Matteo' Foundation, Pavia, Italy (PP); Dipartimento Medicina di Laboratorio, SC Anatomia ed Istocitopatologia Diagnostica e di Screening, A.O.U. Città della Salute e della Scienza di Torino, Università di Torino, Turin, Italy (AS); N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia (VS); German Breast Group & University of Frankfurt, Neu-Isenburg, Germany (GvM); The Russell H. Morgan Department of Radiology · Pubmed 26063896
2013
  • Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. Electronic address: · Pubmed 23777741
Probable:    Miscellaneous institutions in Milan      
2016
  • Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologica di Milano, Via Ripamonti, 435, 20141, Milan, Italy. · Institut régional du Cancer de Montpellier, Montpellier, France. · Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Clinique Saint-Pierre, Ottignies, Belgium. · Oncology-Hematology Department, Grand Hopital de Charleroi, Charleroi, Belgium. · Centre d'Oncologie de Gentilly, Nancy, France. · Medical Oncology Unit, 'Tor Vergata' University Hospital, Rome, Italy. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · GSK Vaccines, Rixensart, Belgium. · Pubmed 26975189
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 105 total) written by Giuseppe Curigliano about Breast Neoplasms:

  • Inflammatory breast cancer and chest wall disease: The oncologist perspective. 2018
  • Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer. 2018
  • Comparing granulocyte colony-stimulating factor filgrastim and pegfilgrastim to its biosimilars in terms of efficacy and safety: A meta-analysis of randomised clinical trials in breast cancer patients. 2018
  • The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. 2018
  • A rude awakening from tumour cells. 2018
  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). 2017
  • 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 2017
  • From the maximum tolerable to the minimum effective treatment: The Umberto Veronesi's life commitment to breast cancer care. 2017
  • Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice. 2017
  • Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures. 2017
Show List of Full Article Records
Google Searches

Learn more about Giuseppe Curigliano using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
European Institute of Oncology
University of Milan Statale
Miscellaneous institutions in Milan
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
European Institute of Oncology
2018
  • University of Milano, Department of Oncology and Hemato-Oncology, Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 30032791
  • a Division of Early Drug Development , European Institute of Oncology , Milan , Italy. · b Department of Oncology and Hematology , University of Milan , Milan , Italy. · Pubmed 29355400
  • Women and Children's Division, Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway; Department of Bowel Cancer Screening, Cancer Registry of Norway, Oslo, Norway. · Hexal AG, Holzkirchen, Germany. · European Institute of Oncology, Division of New Drug Development, Italy; Department of Oncology and Hematology, University of Milano, Milano, Italy. Electronic address: · Pubmed 29227817
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • European Institute of Oncology, Milano, Italy. Electronic address: · Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milano, Italy. · European Institute of Oncology, Milano, Italy; University of Milan, Milano, Italy. · European Institute of Oncology, Milano, Italy. · Pubmed 27876474
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • a Division of Early Drug Development , European Institute of Oncology , Milan , Italy. · b Department of Oncology and Hematology , University of Milan , Milan , Italy. · Pubmed 28718331
  • Giuseppe Curigliano and Carmen Criscitiello, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 28661760
  • a Early Drugs Development for Innovative Therapies Division , European Institute of Oncology , Milan , Italy. · b Division of Senology , European Institute of Oncology , Milan , Italy. · c School of Medicine , University of Milano , Milan , Italy. · Pubmed 28395543
  • Azienda Ospedaliero Universitaria Careggi - University of Florence, Largo G.A. Brambilla 3, 50134, Florence, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Azienda Ospedaliero Universitaria Careggi - University of Florence, Largo G.A. Brambilla 3, 50134, Florence, Italy. · Breast Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy. · Medical Oncology Unit, Presidio Ospedaliero Felice Lotti, Pontedera, Italy. · UOC di Oncologia, Ospedale Versilia, Istituto Toscano Tumori, Lido di Camaiore, Italy. · Dipartimento Oncologico ASST - Bergamo Ovest, Treviglio, Italy. · Medical Oncology Unit, Ospedale Misericordia, Grosseto, Italy. · Division of Medical Oncology 2, Istituto Oncologico Veneto, Padua, Italy. · Medical Oncology Unit, Azienda Ospedaliera Sant'Andrea, Rome, Italy. · Breast Unit, Santa Maria Annunziata Hospital, Florence, Italy. · SC Oncologia, Ospedale Ss. Antonio e Biagio e C. Arrigo, Alessandria, Italy. · Medicina Interna 1, Ospedale San Giuseppe, Empoli, Italy. · Pubmed 28364270
  • Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St., Dublin, 7, Ireland. · Division of Early Drug Development, Istituto Europeo di Oncologia, Milan, Italy. · Clinical Investigational Unit, Institut Curie, Paris, France. · Breast UnitKliniken Essen-Mitte, Essen, Germany. · Department of Obstetrics & Gynecology, St.-Johannes-Hospital, Dortmund, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-EMN, Erlangen, Germany. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Department of Medical Oncology, Centre Leon Berard, Lyon, France. · Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Department of Clinical Oncology, Nottingham University Hospital NHS Trust (City campus), Nottingham, UK. · Unit of Medical Oncology, Santa Chiara Hospital, Trento, Italy. · Division of Hematology/Oncology, University of Tennessee Health Science Center, The West Clinic, Medical Oncology, Memphis, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · MGH Cancer Center, Massachusetts General Hospital, Boston, USA. · Pubmed 28176175
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Hematology and Oncology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Medical Oncology, Karmanos Cancer Institute, Detroit, MI, USA. · Yale Cancer Center, New Haven, CT, USA. · Breast Cancer Research Program, Stanford Cancer Institute, Stanford, CA, USA. · Pfizer Oncology, Groton, CT, USA. · Pfizer Oncology, Milan, Italy. · Pfizer Oncology, San Diego, CA, USA. · Pubmed 27906684
  • Division of Early Drug Development, European Institute of Oncology, Milano, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, Italy; Department of Haematology and Oncology, University of Milano, Italy. · Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy. · Division of Early Drug Development, European Institute of Oncology, Milano, Italy; Department of Haematology and Oncology, University of Milano, Italy. Electronic address: · Pubmed 29154173
  • Department of Radiological Science and Radiation Therapy, IEO European Institute of Oncology, Milan, Italy; Department of Oncology, Università degli Studi di Milano, Milan, Italy. Electronic address: · Università degli Studi di Milano, Postgraduation School in Radiodiagnostics, Milan, Italy. Electronic address: · Università degli Studi di Milano, Postgraduation School in Radiodiagnostics, Milan, Italy. Electronic address: · Università degli Studi di Milano, Postgraduation School in Radiodiagnostics, Milan, Italy; Present address: Department of Imaging, CDI Centro Diagnostico Italiano, Via Simone Saint Bon, Milan, Italy. Electronic address: · New Drugs and Early Drug Development for Innovative Therapies Division, IEO European Institute of Oncology, Milan, Italy. Electronic address: · Division of Epidemiology and Biostatistics, IEO European Institute of Oncology, Milan, Italy. Electronic address: · Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia and Division of Radiology, National Center of Oncological Hadrontherapy (CNAO Foundation), Italy. Electronic address: · Pubmed 28987705
  • Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Medical Oncology, Institut Jules Bordet, UniversitÕ Libre de Bruxelles, Brussels, Belgium. · Tumor and Breast Center ZeTuP, St. Gallen. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N. Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku, Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 28838210
  • APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: · European Institute of Oncology, Milan, Italy. · University Medical Center, Hamburg, Germany. · Copenhagen University Hospital, Copenhagen, Denmark. · Sussex Health Outcomes, Research & Education in Cancer (SHORE-C), University of Sussex, East Sussex, UK. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University Hospital Jean Minjoz, Besançon, France. · Pubmed 28549309
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Istituto Europeo di Oncologia, Division of Early Drug Development for Innovative Therapies, Via Ripamonti 435, 20133 Milano, Italy. Electronic address: · Istituto Europeo di Oncologia, Division of Early Drug Development for Innovative Therapies, Via Ripamonti 435, 20133 Milano, Italy. · Division of Pathology, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy; University of Milan, Breast Cancer Program, Via Ripamonti 435, 20133 Milano, Italy. · Pubmed 27866835
  • Division of Breast Surgery, European Institute of Oncology, Milan, Italy. Electronic address: · Division of Breast Surgery, European Institute of Oncology, Milan, Italy. · Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Pubmed 27810700
2016
  • Division of Experimental Cancer Medicine, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 27600532
  • Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · Department of Breast Oncology Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA. Electronic address: · Department of Surgery, McGill Hospital, Boston, MA, USA. Electronic address: · Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · Department of Clinical Medicine and Surgery, University Federico II, Corso Umberto I 40, Naples, Italy. Electronic address: · Division of Experimental Therapeutics, European Institute of Oncology, Via G. Ripamonti 435, Milan, Italy. Electronic address: · General Surgery, Department of Advanced Biomedical Science, University Federico II, Corso Umberto I 40, Naples, Italy. Electronic address: · Department of Surgery, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 27825710
  • Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 27744144
  • IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Boston, MA, USA. · Harvard T. H. Chan School of Public Health, Boston, MA, USA. · IBCSG Central Pathology Laboratory, Department of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · University of Milan, Milan, Italy. · Division of Experimental Therapeutics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · National Institute of Oncology, Ráth György u. 7/9, Budapest, 1122, Hungary. · Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Viale Settembrini 2, 47923, Rimini, Italy. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Pubmed 27372069
  • Istituto Europeo di Oncologia, via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Servicio Oncologia Médica, Vall d'Hebron University Hospital, Vall d'Hebron 119-129, 08035, Barcelona, Spain. · The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX, 77030, USA. · Istituto Oncologico Veneto, Via Gattamelata 64, 35128, Padua, Italy; University of Padova, Via Giustiniani 22, 35121, Padua, Italy. · University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands; Erasmus Medical Center Cancer Institute, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Highlands Oncology Group, 3232 N North Hills Blvd, Fayetteville, AR, 72703, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. · Oncología Médica, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. · Centre Jean Perrin, Unicancer and EA 4677 Université d'Auvergne, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Novartis Institutes for BioMedical Research, 230 Massachusetts Avenue, Cambridge, MA, 02139, USA. · University of California, Los Angeles, 2825 Santa Monica Blvd, Suite 211, Santa Monica, CA, 90404, USA. · Pubmed 27336726
  • Levine Cancer Institute, Charlotte, NC, USA. · Mission Health Asheville, Asheville, NC, USA. · Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141, Milan, Italy. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Sylvester Comprehensive Cancer Center at Deerfield Beach, Miller School of Medicine, University of Miami, Miami, FL, USA. · The Northern Hospital, Cooper St, Epping, Australia. · Department of Medical Oncology, Léon-Bérard Centre, Lyon, France. · Oncology-Hematology Department, Grand Hopital de Charleroi, Charleroi, Belgium. · Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, WA, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Clinique du sein, Centre du Cancer, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. · Department of Oncology, KU Leuven and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium. · Roswell Park Cancer Institute, Buffalo, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · Vianova-Biosciences, Lasne, Belgium. · Pubmed 26993131
  • Department of Experimental Oncology, European Institute of Oncology, Milan 20141, Italy. · Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan 20139, Italy. · Department of Molecular and Cellular Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan 20141, Italy. · School of Medicine, University of Milan, Milan 20122, Italy. · Biobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Milan 20141, Italy. · Department of Oncology, University of Milan, Milan 20139, Italy. · Pubmed 27779108
  • Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milano, Italy. · Division of Epidemiology and Biostatistics, Istituto Europeo di Oncologia, Milano, Italy. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 27323400
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy Program of Breast Health (Senology), European Institute of Oncology, Milan, Italy · Program of Breast Health (Senology), European Institute of Oncology, Milan, Italy. · Pubmed 26002609
  • Division of Experimental Cancer Medicine, European Institute of Oncology, Milan, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy; Breast Center, Baylor College of Medicine, Houston, TX, USA. · Medical Oncology, Istituto Nazionale Tumori - IRCCS Fondazione Pascale, Napoli, Italy. · Medical Oncology, Azienda Ospedaliera Universitaria Federico II, Napoli, Italy. · General Surgery, Department of Advanced Biomedical Science, University Federico II, Napoli, Italy. · Department of Surgery, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. · General Surgery, Department of Advanced Biomedical Science, University Federico II, Napoli, Italy. Electronic address: · Pubmed 26238477
  • Department of Pathology, Yale University, New Haven, USA · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, USA. · Oncology Centre, Cambridge University Hospitals National Health Services Foundation Trust, Cambridge, UK. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Essligen, Germany. · Institute of Pathology, Medical University of Graz, Graz Breast Center Salzburg, Paracelsus Medical University, University Hospital Salzburg, Salzburg, Austria. · German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA. · Institute of Pathology, Charité Hospital, Campus Mitte, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux. · Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh, UK. · Pubmed 26019189
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Affiliations of authors: Division of Experimental Cancer Medicine, European Institute of Oncology, Milan, Italy (AE, CC, GC). · Affiliations of authors: Division of Experimental Cancer Medicine, European Institute of Oncology, Milan, Italy (AE, CC, GC). · Pubmed 26063887
  • European Institute of Oncology, Medical Oncology, Milan, Italy. Electronic address: · European Institute of Oncology, Division of Epidemiology and Biostatistics, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · European Institute of Oncology, Medical Oncology, Milan, Italy. · European Institute of Oncology, Division of Pathology and Laboratory Medicine, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · European Institute of Oncology, Division of Plastic Reconstruction Surgery, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, Milan, Italy. · Pubmed 25908443
2014
  • Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 25279960
  • Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milano, Italy · Division of Hematology/Medical Oncology and Cancer Biology, Mayo Clinic Cancer Center, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 24950980
  • Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 24727984
  • Department of Medical Oncology, University Hospital Jean Minjoz, Besançon · Medical Oncology Department, APHP Hôpital Tenon, Paris UPMC, Institut Universitaire de Cancérologie, Paris, France. · Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark. · Division of Medical Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, UK. · Global Medical Affairs, F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Pubmed 25070545
  • European Institute of Oncology, Medical Oncology, Milan, Italy · European Institute of Oncology, Division of Epidemiology and Biostatistics and Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · European Institute of Oncology, Medical Oncology, Milan, Italy. · European Institute of Oncology, Division of Plastic Reconstruction Surgery, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, Milan, Italy. · Pubmed 25368274
  • Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Department of Breast Oncology, National Cancer Institute "Fondazione Pascale", Naples, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Napoli, Italy. · Department of Advanced Medical Sciences, Operative Unit of General Surgery and Transplants, University of Naples Federico II, Napoli, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan, Italy. · Early Drug Development for Innovative Therapies Division, Department of Medicine, European Institute of Oncology, Milan, Italy. Electronic address: · Pubmed 24314620
  • European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. Electronic address: · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy. · European Institute of Oncology, Division of Pathology, via Ripamonti 435, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · European Institute of Oncology, Division of Epidemiology and Biostatistics, via Ripamonti 435, Milan, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, via Bicocca degli Arcimboldi 8, 20126 Milan, Italy. · European Institute of Oncology, Medical Oncology, via Ripamonti 435, Milan, Italy. · Second University of Naples, Medical Oncology, via Pansini 5, Naples, Italy. · Pubmed 24269135
2013
  • Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 24074802
  • Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milano, Italy. Electronic address: · Pubmed 23958375
2012
  • Division of Medical Oncology, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italia. · Pubmed 22229343
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 21764517
2011
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 22015297
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano 20141, Italy. · Pubmed 22043054
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 21343379
  • Department of Medicine, Division of Medical Oncology, Milano, Italy. · Pubmed 20610479
2009
  • European Institute of Oncology, Department of Medicine, Division of Medical Oncology, Via Ripamonti 435, Milan, Italy. · Pubmed 19914543
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 19884553
2017
  • New Drugs Development Division, European Institute of Oncology, Milan, Italy. · Pubmed 28914645
  • Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Pubmed 28872469
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2015
  • aDivision of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan bDipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, Napoli, Italy. · Pubmed 26397764
  • Medical Oncology Unit (VA, ABe), University of Brescia, and Breast Unit (RP, LV, ELS) Spedali Civili Hospital, Brescia, Italy; U.O. Multidisciplinare di Patologia Mammaria, S.S. Terapia Molecolare e Farmacogenomica, AZ. Istituti Ospitalieri di Cremona, Cremona, Italy (DG, AR, MRC, LD, ABo); Departments of Radiation Oncology (TB) and Pathology (FS), University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA (MC); Division of Experimental Therapeutics, Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy (GC); Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine (MGD), and Medical Oncology Unit (SDC), Fondazione IRCCS - Istituto Nazionale Tumori, Milan, Italy (MGD); Academic Department of Biochemistry, Biochemical Endocrinology (MD), Department of Surgery, Breast Unit (PB), and The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research and Breast Unit (MD, GS), Royal Marsden Hospital, London, UK; Department of Pathology, Melbourne University, Parkville, Australia (SF); Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (ALH); Mount Vernon Cancer Centre, London, UK (AM); Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT (CH); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Division of Medical Oncology, Department of Hemato-oncology, IRCCS Policlinico 'San Matteo' Foundation, Pavia, Italy (PP); Dipartimento Medicina di Laboratorio, SC Anatomia ed Istocitopatologia Diagnostica e di Screening, A.O.U. Città della Salute e della Scienza di Torino, Università di Torino, Turin, Italy (AS); N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia (VS); German Breast Group & University of Frankfurt, Neu-Isenburg, Germany (GvM); The Russell H. Morgan Department of Radiology · Pubmed 26063896
2014
  • Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 25279962
  • Istituto Europeo di Oncologia, Division of Early Drug Development for Innovative Therapies , Via Ripamonti 435, 20133 Milano , Italy +39 02 57489439 ; +39 02 94379224 ; · Pubmed 25107301
  • Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Pubmed 25080998
  • Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 24762078
  • Istituto Europeo di Oncologia, Division of Early Drug Development for Innovative Therapies , Via Ripamonti 435, 20133 Milano , Italy +39 02 57489788 ; +39 02 57489581 ; · Pubmed 24597540
  • Authors' Affiliations: Breast Cancer Program, Division of Early Drug Development, Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan; and Department of Advanced Biomedical Sciences, Operative Unit of General Surgery and Transplants, University Naples Federico II, Napoli, Italy. · Pubmed 24165579
2013
  • Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 24076578
  • Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy. · Pubmed 23915740
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 22541668
  • Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy; Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy. Electronic address: · Pubmed 23953055
  • Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. Electronic address: · Pubmed 23777741
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23642529
  • Department of Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 23393126
  • Medical Oncology, European Institute of Oncology , Milan , Italy. · Pubmed 23327413
  • Division of Plastic Reconstruction Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy. · Pubmed 23313014
2012
  • Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Pubmed 21715566
  • European Institute of Oncology, Medical Oncology, Milan, Italy. · Pubmed 22827581
  • Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy. · Pubmed 23040002
  • Division of Plastic Reconstruction Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22820937
  • Department of Medicine, Division of Medical Oncology, Istituto Europeo di Oncologia, Milano, Italy. · Pubmed 22547541
  • Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy. · Pubmed 22467243
  • Division of Plastic Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 22231025
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. · Pubmed 22212746
  • Division of Plastic Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 21610155
2011
  • Division of Plastic Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 22024947
  • Division of Reconstructive Surgery, European Institute of Oncology, Milan, Italy. · Pubmed 21295982
  • Divisione di Radiologia, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milano, Italy. · Pubmed 21225368
  • Division of Senology, European Institute of Oncology, IEO, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 20740312
2010
  • Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Pubmed 20920984
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. · Pubmed 19967556
  • Division of Medical Oncology, European Institute of Oncology, via Ripamonti 435, Milan, Italy. · Pubmed 19884008
University of Milan Statale
2018
  • University of Milano, Department of Oncology and Hemato-Oncology, Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address: · Pubmed 30032791
  • a Division of Early Drug Development , European Institute of Oncology , Milan , Italy. · b Department of Oncology and Hematology , University of Milan , Milan , Italy. · Pubmed 29355400
  • Women and Children's Division, Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway; Department of Bowel Cancer Screening, Cancer Registry of Norway, Oslo, Norway. · Hexal AG, Holzkirchen, Germany. · European Institute of Oncology, Division of New Drug Development, Italy; Department of Oncology and Hematology, University of Milano, Milano, Italy. Electronic address: · Pubmed 29227817
2017
  • Division of Early Drug Development, European Institute of Oncology, Milano, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, Italy; Department of Haematology and Oncology, University of Milano, Italy. · Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, Italy. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy. · Division of Early Drug Development, European Institute of Oncology, Milano, Italy; Department of Haematology and Oncology, University of Milano, Italy. Electronic address: · Pubmed 29154173
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2015
  • Medical Oncology Unit (VA, ABe), University of Brescia, and Breast Unit (RP, LV, ELS) Spedali Civili Hospital, Brescia, Italy; U.O. Multidisciplinare di Patologia Mammaria, S.S. Terapia Molecolare e Farmacogenomica, AZ. Istituti Ospitalieri di Cremona, Cremona, Italy (DG, AR, MRC, LD, ABo); Departments of Radiation Oncology (TB) and Pathology (FS), University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA (MC); Division of Experimental Therapeutics, Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy (GC); Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine (MGD), and Medical Oncology Unit (SDC), Fondazione IRCCS - Istituto Nazionale Tumori, Milan, Italy (MGD); Academic Department of Biochemistry, Biochemical Endocrinology (MD), Department of Surgery, Breast Unit (PB), and The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research and Breast Unit (MD, GS), Royal Marsden Hospital, London, UK; Department of Pathology, Melbourne University, Parkville, Australia (SF); Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (ALH); Mount Vernon Cancer Centre, London, UK (AM); Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT (CH); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Division of Medical Oncology, Department of Hemato-oncology, IRCCS Policlinico 'San Matteo' Foundation, Pavia, Italy (PP); Dipartimento Medicina di Laboratorio, SC Anatomia ed Istocitopatologia Diagnostica e di Screening, A.O.U. Città della Salute e della Scienza di Torino, Università di Torino, Turin, Italy (AS); N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia (VS); German Breast Group & University of Frankfurt, Neu-Isenburg, Germany (GvM); The Russell H. Morgan Department of Radiology · Pubmed 26063896
2013
  • Division of Senology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. Electronic address: · Pubmed 23777741
Miscellaneous institutions in Milan
2016
  • Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologica di Milano, Via Ripamonti, 435, 20141, Milan, Italy. · Institut régional du Cancer de Montpellier, Montpellier, France. · Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Clinique Saint-Pierre, Ottignies, Belgium. · Oncology-Hematology Department, Grand Hopital de Charleroi, Charleroi, Belgium. · Centre d'Oncologie de Gentilly, Nancy, France. · Medical Oncology Unit, 'Tor Vergata' University Hospital, Rome, Italy. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · GSK Vaccines, Rixensart, Belgium. · Pubmed 26975189
University of Milan Bicocca
2016
  • Division of Experimental Therapeutics, University of Milan-Bicocca, Milan, Italy. · Division of Epidemiology and Biostatistics, University of Milan-Bicocca, Milan, Italy Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. · Department of Pathology, School of Medicine, University of Milan, Milan, Italy. · Division of Epidemiology and Biostatistics, University of Milan-Bicocca, Milan, Italy. · Breast Health Program, European Institute of Oncology, Milan, Italy. · Division of Experimental Therapeutics, University of Milan-Bicocca, Milan, Italy · Pubmed 27354620
Unspecified
2015
  • Division of Experimental Therapeutics · Division of Epidemiology and Biostatistics. · Division of Experimental Therapeutics. · Department of Pathology and Laboratory Medicine School of Medicine, University of Milano, Milan. · Division of Cancer Prevention and Genetics. · Division of Senology. · School of Medicine, University of Milano, Milan Department of Medical Imaging and Radiation Sciences. · Breast Health Program, European Institute of Oncology, Milan, Italy. · Pubmed 25600567
Miscellaneous cities in Italy
2015
  • Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. Electronic address: · Division of Epidemiology and Biostatistics, Istituto Europeo di Oncologia, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy. · Laboratory Division of Hematology-Oncology, Italy. · Department of Experimental Oncology, Italy; University of Milano, School of Medicine, Milano, Italy. · Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. · Department of Pathology, Istituto Europeo di Oncologia, Italy; University of Milano, School of Medicine, Milano, Italy. · Pubmed 25772326
76 Other Locations Show
Yearly article counts 52010121813129420